hottips

calculated risk-taker. investor. CPA, MBA.

[Sama Hoole @SamaHoole]

1918: they sold radioactive water as a health tonic. It was radium, and it dissolved men's jaws.

1898: they sold heroin as a children's cough syrup. It was heroin.

1863: they sold cocaine wine as a daily pick-me-up. Popes and presidents put their names to it.

1946: they sold cigarettes on a doctor's recommendation. Whole campaigns ran on which brand physicians preferred.

1960s: they sold margarine as the heart-healthy fat. It was loaded with the trans fat that actually stops hearts.

Every one of these came with an expert's blessing and total confidence.

The people telling you today which fat to fear are the institutional descendants of the ones who put radium in your water and a doctor's face on a cigarette packet.

"The experts recommend it" has a body count going back a century.

[Michael A. Arouet @MichaelAArouet]

Wealth tax explained:

1. Laura loves to cook, she risks all her life savings and opens a small restaurant: Laura‘s Kitchen

2. Laura works really hard, evenings, weekends, no vacations

3. The local community loves Laura‘s Kitchen, it’s a success, the restaurant gets larger, Laura hires 30 people from the neighborhood

4. Laura makes 1,5 Million € in profit, she pays 40% in income tax: 600,000€

5. The left „tax the rich“ party wins the elections, and introduces a wealth tax

6. Laura‘s Kitchen gets valued by the tax authorities at 25 Million €. Laura must pay 5% wealth tax: 1,25 Million €

7. The income tax of 600,000€ plus 1,25 Million € in wealth tax is more than the 1,5 Million € Laura makes

8. Laura cannot afford to pay more taxes than she makes, she closes Laura’s Kitchen

9. Laura loses her life savings despite years of hard work, 30 people lose their jobs, the state receives zero taxes

10. The local community goes to McDonalds again

11. The local left “tax the rich“ party members blame „capitalism“ for that on social media

12. Everyone gets poorer due to higher unemployment and lower tax revenues

Why is this so difficult for the left to understand?

[hottips @hottips888]

@oshea9_harry @grok @Lancepantsalot @DrPatrick Lol, that didn't work out too well for you. Still arguing with grok when it had a different result than what you expected. 🤣

[hottips @hottips888]

@MK2forU Nice. Does this mean GT is a good gamble at this point?

[hottips @hottips888]

$IBRX

[Macro Ghost on Youtube @Deepvalue69420]

$ibrx is a threat to the old order

[hottips @hottips888]

@gainzalgo can you please explain/clarify your statement for non-medical person? is this positive or negative? cheers.

[𝒰𝓂𝒷𝒾𝓈𝒶𝓂 @Umbisam]

Institutional ownership in $IBRX just hit a new all-time high. Smart money continues to accumulate aggressively as the ANKTIVA expansion story strengthens. @DrPatrick

[GainzAlgo @gainzalgo]

$IBRX

This is the part the market keeps sleeping on.

Anktiva is not just another biotech headline. Its whole mechanism is built around activating IL-15 biology and expanding NK cells + T cells — the immune cells the body needs to fight cancer.

Patient charts are already showing ALC recovery. Dr. Patrick has explained the why and the how.

The frustrating part? The science is sitting right in front of everyone, but access still moves at the speed of bureaucracy.

This story is much bigger than most people realize.

[hottips @hottips888]

$IBRX

[Miles Jane @KelseyHard10948]

$IBRX Anktiva performed better than Revolution's drug in pancreatic cancer trials. Revolution's trial included second-line patients only who failed one prior therapy. Ibrx's pancreatic cancer trial patients were 3rd through 6th line who failed multiple prior therapies and had much higher tumor burden than Revolution's cohort. Outcome comparison - ibrx - over double the average suvival. Revolution - a little under double survival. Ibrx's results were materially better given the much sicker patient cohort. Also, Revolution excluded 10% of pancreatic cancer patients who didn't have the required genetic component. Ibrx had no restrictions.

[Dr. Wojak, M.D. @DrWojakMD]

Presented without comment.

[hottips @hottips888]

$OPM #PSE
Up around 30-40% since last post mid 2025.

Share buyback going slow and steady. So far the gameplan seems to be waiting for each bid level to dry up then hitting the ask side. Rinse and repeat. Hoping to end the year around 0.015 at least plus another cash div.

[hottips @hottips888]

$OPM #PSE (P0.01): Negative Risk

With the recent announcement of its P200M share buyback. Current prices still presents a negative risk investment (imho).

Why?

NBV and net cash/near cash equivelent per share is at P0.02+

Negative risk until P0.02 plus upside play for new dev

[hottips @hottips888]

$NRCP got in around the time I posted 2024.

Finally, the investment thesis played out. Started giving dividends again. Declared P0.137/share div and set a 30% payout ratio based on prior year's earnings.

Those who bought at 0.60-0.70 will enjoy 17-20% net of tax.

Good times!

[hottips @hottips888]

$NRCP #PSE

Hype lng daw price movement?
You decide for yourselves.

Highest net income ever since IPO. Prices haven't recovered to its previous levels even when the income wasn't as high as it is today.

While nothing is 100%, I'm inclined to believe early bird gets the worm.

[hottips @hottips888]

@prosperousguy @gainzalgo This comment shows you need more exposure and understanding than just looking at the OS share count itself. I can argue with you that a startup with 10m shares may surpass 1B shares just to reach half of what IBRX is now.

[hottips @hottips888]

@gainzalgo Added more on the dip at $7.30.. my logic being these new data makes my entry (though way higher than my core at 2.30s) is less risky than when I jumped in last December when there were more unknowns tham today.

but my risk mgmt is, buy not more than half of my core at 2+

[hottips @hottips888]

$IBRX
Though I am no expert in technical readings, I interpret these two candles as bullish. Still respecting the previous resistance now turned into support line. In 2 occassions, selloff met with immediate buying up to the MA20 and 50. Patience needed.

[hottips @hottips888]

@gainzalgo $IBRX touched the 50dma and bounced up. added a few shares near the 7.90 levels.
10dma/20dma is about to cross the 50dma as well.
observing the next few trading sessions, might add a bit more near the 50dma area.

[hottips @hottips888]

@gainzalgo despite the dump, $IBRX just lost just <$0.50+ and still holding above the moving average lines.. this is considered good sign indeed. Jane Street supplied the liquidity. Let's see the next few trading sessions, if no big sellers come out, prices might move up fast due to demand.

[hottips @hottips888]

@DrPatrick Is this under the $IBRX company?

[hottips @hottips888]

@adamfeuerstein @DrPatrick Hope Dr. Pat and his legal team haul you to court for this..
"IBRX CULT purposely built" is bordering on lible/defamation.. it is a very serious accusation and his legal team should teach you a lesson. Screenshot this peeps and send to @DrPatrick @immu

[hottips @hottips888]

$IBRX

[GainzAlgo @gainzalgo]

$IBRX So I updated the graphic using the latest 13F data from Fintel, and it’s now showing 209M institutional shares owned. That would shrink the free float down to roughly 80M shares, largely due to Vanguard’s position, and push the real short interest to an insane 173%.
What exactly is going on with the 209M institutional shares figure? Is this a reporting glitch or a Fintel system bug? Any tech/data experts want to weigh in?
If this number is accurate… this situation is absolutely wild.